Comparative morphological and immunohistochemical study of human meningioma after intracranial transplantation into nude mice

Journal of Neuroscience Methods

Volumn 205, Issue 1, 2012, Pages 1-9

  Friedrich, Sabrina ^a   Schwabe, Kerstin ^a   Klein, Rüdiger ^a,b   Krusche, Claudia A ^a,c   Krauss, Joachim K ^a   Nakamura, Makoto ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Institute for Molecular and Cellular Anatomy ^*  (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

EMA; Orthotop; Primary cell culture; Proliferations index; VWF; Xenotransplantation

Indexed keywords

CYCLOOXYGENASE 2; EPITHELIAL MEMBRANE ANTIGEN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; MICROVESSEL DENSITY; MORPHOMETRICS; MOUSE; NONHUMAN; NUDE MOUSE; ONCOLOGICAL PARAMETERS; PREFRONTAL CORTEX; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROLIFERATION INDEX; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME;

EID: 84855778510     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.12.009     Document Type: Article

References (40)

1. Abou-Issa H.M., Alshafie G.A., Seibert K., Koki A.T., Masferrer J.L., Harris R.E. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res 2001, 21:3425-3432.
2. Baia G.S., Dinca E.B., Ozawa T., Kimura E.T., McDermott M.W., James C.D., et al. An orthotopic skull base model of malignant meningioma. Brain Pathol 2008, 18:172-179.
3. Cargioli T.G., Ugur H.C., Ramakrishna N., Chan J., Black P.M., Carroll R.S. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery 2007, 60:750-759.
4. Carroll R.S., Glowacka D., Dashner K., Black P.M. Progesterone receptor expression in meningiomas. Cancer Res 1993, 53:1312-1316.
5. Clark R. Human breast cancer cell line xenografts as models of breast cancer - the immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat 1996, 39:69-86.
6. Condra K., Buatti J., Mendenhall W., Friedman W.A., Marcus R.B., Rhoton A. Bening meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997, 39:427-436.
7. Howe L.R., Subbaramaiah K., Patel J., Masferrer J.L., Deora A., Hudis C., et al. Celecoxib a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res 2002, 62:5405-5407.
8. Hsu A.L., Ching T.T., Wang D.S., Song X., Rangnekar V.M., Chen C.S. The cyclooxygenase-2 inhibitor celecoxib induced apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 2000, 275:11397-11403.
9. Jensen R.L., Leppla D., Rokosz N., Wurster R.D. Matrigel augments xenograft transplantation of meningioma cells into athymic mice. Neurosurgery 1998, 42:130-135.
10. Kundu N., Fulton A.M. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 2002, 62:2343-2346.
11. Langford L.A. Pathology of meningiomas. J Neurooncol 1996, 29:217-221.
12. Malham G.M., Thomsen R.J., Synek B.J., Baguley B.C. Establishment of primary human meningiomas as subcutaneous xenografts in mice. Br J Neurosurg 2001, 15:328-334.
13. Marosi C., Hassler M., Roessler K., Reni M., Sant M., Mazza E., et al. Meningioma. Crit Rev Oncol Hematol 2008, 67:153-171.
14. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000, 60:1306-1311.
15. Matsuda Y., Kawamoto K., Kiya K., Kurisu K., Sugiyama K., Uozumi T. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 1994, 80:527-534.
16. Mc Cutcheon I.E., Friend K.E., Gerdes T.M., Zhang B.M., Wildrick D.M., Fuller G.N. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J Neurosurg 2000, 92:306-314.
17. Medhkour A., Van R.M., Sobel R.A., Fingert H.J., Lee J., Martuza R.L. Implantation of human meningiomas into the subrenal capsule of the nude mouse A model for studies of tumor growth. J Neurosurg 1989, 71:545-550.
18. Meis J.M., Odonez N.G., Meningiomas Bruner J.M. An immunohistochemical study of 50 cases. Arch Pathol Lab Med 1986, 110:934-937.
19. Mirimanoff R.Q., Dosoretz D.E., Linggood R.M., Ojemann R.G., Martuza R.L. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985, 62:18-24.
20. Mukherjee P., Basu G.D., Tinder T.L., Subramani D.B., Bradley J.M., Arefayene M., et al. Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. J Immunol 2009, 182:216-224.
21. Nakamura M., Roser F., Michel J., Jacobs C., Samii M. The natural history of incidental meningiomas. Neurosurgery 2003, 53:62-70.
22. Olson J.J., Beck D.W., Schlechte J.A., Loh P.M. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 1987, 66:584-587.
23. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates 2011, Academic Press, San Diego.
24. Perry A., Louis D.N., Kleihues P., Scheithauer B.W., Burger P.C., Budka H., et al. Meningeal tumors. WHO classification of tumours of the central nervous system 2007, 164-172. IARC Press, Lyon. D.N. Louis, H. Ohgaki, O.D. Wistler, W.K. Cavenee (Eds.).
25. Püttmann S., Senner V., Braune S., Hillmann B., Exeler R., Rickert C.H., et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 2005, 85:1163-1171.
26. Ragel B.T., Couldwell W.T., Gillepsi G.Y., Wendland M.M., Whang K., Jensen R.L. A comparison of the cell lines used in meningioma research. Surg Neurol 2008, 70:295-307.
27. Ragel B.T., Elam I.L., Gillepsi G.Y., Flynn J.R., Kelly D.A., Mabey D., et al. A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. J Neurosurg 2008, 108:304-310.
28. Ragel B.T., Jensen R.L., Gillespie D.L., Prescott S.M., Couldwell W.T. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 2007, 109:588-597.
29. Rana M.W., Pinkerton H., Thornton H., Nagy D. Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice. Proc Soc Exp Biol Med 1977, 155:85-88.
30. Reichle A., Vogt T., Coras B., Terheyden P., Neuber K., Trefzer U., et al. Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res 2007, 17:360-364.
31. Remmele W., Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987, 8:138-140. [Article in German].
32. Shintaku M., Honda T., Sakai T. Expression of podoplanin and calretinin in meningioma: an immunohistochemical study. Brain Tumor Pathol 2010, 27:23-27.
33. Sooriakumaran P., Coley H.M., Fox S.B., Macanas-Pirard P., Lovell D.P., Henderson A., et al. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. Anticancer Res 2009, 29:1483-1488.
34. Stafford S.L., Perry A., Suman V.J., Meyer F.B., Scheithauer B.W., Lohse C.M., et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo clinic patients, 1978 through 1988. Mayo Clin Proc 1998, 73:936-942.
35. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancinoma. J Natl Cancer Inst 1992, 84:1875-1887.
36. Weisman A.S., Villemure J.G., Kelly P.A. Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 1986, 46:2545-2550.
37. Williams C.S., Tsujii M., Reese J., Dey S.K., BuBois R.N. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000, 105:1589-1594.
38. Winek R.R., Scheithauer B.W., Wick M.R. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma A immunohistochemical comparative study. Am J Surg Pathol 1989, 13:251-261.
39. Yazaki T., Manz H.J., Rabkin S.D., Martuza R.L. Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. Cancer Res 1995, 55:4752-4756.
40. Yazaki T., Takamiya Y., Costello P.C., Mineta T., Menon A.G., Rabkin S.D., et al. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. J Neurooncol 1995, 23:23-29.